KCA
Search
- Page Path
- HOME > Search
Original Article
- Lung and Thoracic cancer
- The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer
- Yeonseok Choi, Jae Myoung Noh, Sun Hye Shin, Kyungjong Lee, Sang-Won Um, Hojoong Kim, Hongryull Pyo, Yong Chan Ahn, Byeong-Ho Jeong
- Cancer Res Treat. 2023;55(3):804-813. Published online January 3, 2023
- DOI: https://doi.org/10.4143/crt.2022.1305
-
Abstract
PDF
Supplementary Material
PubReader
ePub - Purpose
This study aimed to investigate cumulative incidence and risk factors associated with chronic pulmonary infection (CPI) development after radiotherapy for lung cancer.
Materials and Methods
We retrospectively analyzed 1,872 patients with lung cancer who received radiotherapy for lung cancer from 2010-2014, had a follow-up period of ≥ 3 months after radiotherapy, and did not have CPI at the time of radiotherapy. CPI was defined as pulmonary tuberculosis, non-tuberculous mycobacterial pulmonary disease, chronic pulmonary aspergillosis, or pulmonary actinomycosis. The cumulative incidence of CPI and overall survival (OS) were estimated using the Kaplan-Meier method, and a multivariable Cox proportional hazards analysis was performed to identify risk factors associated with CPI development.
Results
The median follow-up period was 2.3 years with OS rates of 55.6% and 37.6% at 2 and 5 years, respectively. CPI developed in 59 patients at a median of 1.8 years after radiotherapy, with cumulative incidence rates of 1.1%, 3.4%, 5.0%, and 6.8% at 1, 3, 5, and 7 years, respectively. A lower body mass index, interstitial lung disease, prior pulmonary tuberculosis, larger clinical target volume, history of lung cancer surgery or radiation pneumonitis, and use of inhaled corticosteroids were independent risk factors for CPI development.
Conclusion
The long-term survival rate of lung cancer patients receiving radiotherapy was not low, but the cumulative incidence of CPI gradually increased to 6.8% at 7 years after radiotherapy. Therefore, close monitoring of CPI development is required in surviving patients with risk factors. -
Citations
Citations to this article as recorded by
- A Meta‐Analysis on the Incidence and Associated Factors of Pulmonary Fungal Infections in Lung Cancer Patients: Evidence Predominantly From Chinese Studies in the Chinese and English Literature
Liping Deng, Rong Yu, Bei Chen
Thoracic Cancer.2026;[Epub] CrossRef - External validation and updating of NTCP models for radiation pneumonitis: QUANTEC, Appelt, and a local simplified model
Zhi Chen, Heng Li, Lan Liang, Ming Fan, Shunping Huang, Peng Xue, Rui Kong, Zhenzhou Yang, Zhengjun Guo
Frontiers in Oncology.2026;[Epub] CrossRef - Chronic progressive pulmonary aspergillosis within the irradiated field after stereotactic body radiotherapy: two case reports
Nao Mamuro, Noriko Kishi, Yukinori Matsuo, Masahiro Yoneyama, Hiroyuki Inoo, Minoru Inoue, Takashi Mizowaki
International Cancer Conference Journal.2025; 14(2): 113. CrossRef - Predictive nomogram for risk of pulmonary infection in lung cancer patients undergoing radiochemotherapy: development and performance evaluation
Yujie Huang
American Journal of Cancer Research.2025; 15(2): 781. CrossRef - The Inter-Relationships Among the Risk Factors for Pulmonary Infection and the Diagnostic Utility of Inflammatory Markers in Patients with Non-Small Cell Lung Cancer
Wenwen Qin, Tiebin You, Tai Guo, Ruixin Tian, Xiaoman Cui, Ping Wang
Infection and Drug Resistance.2025; Volume 18: 1111. CrossRef - Incidence and predictors of pulmonary aspergillosis in patients with lung cancer: a systematic review and meta-analysis
Geling Teng, Feng Jin, Hua Zhang, Min Zhang
Frontiers in Medicine.2025;[Epub] CrossRef - Host Risk Factors for Tuberculosis
Vahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, Jalil Rashedi, Hossein Samadi Kafil, Hossein Jalaei Nobari, Ahmad Ali Khalili, Mortaza Raeisi, Mahdi Asghari Ozma, Behroz Mahdavi Poor
Infectious Disorders - Drug Targets.2025;[Epub] CrossRef - Interaction between Dectin-1 gene polymorphisms and low weight on the risk of invasive pulmonary aspergillosis in patients with lung cancer undergoing surgery
Wenfang Jin, Yu Yao, Yanling Lv
Discover Oncology.2025;[Epub] CrossRef - Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management
Wendi Zhou, Hongxu Lu, Jiamin Lin, Jialou Zhu, Jizhen Liang, Yalin Xie, Jinxing Hu, Ning Su
Cancer Reports.2025;[Epub] CrossRef - Risk factors for pulmonary infection after thoracoscopic radical resection of lung cancer in elderly patients with diabetes mellitus
Zi-Yuan Chen, Zhi-Qi Hong, Tie-Qiao Wang, Guo-Mei-Zhi Fu, Wen-Min Su, Cheng-Wei Zhou
World Journal of Diabetes.2025;[Epub] CrossRef - Clinical Analysis of Preoperative Nebulized Inhalation of Budesonide in Reducing Postoperative Complications in Patients Undergoing Lobectomy
紫燕 姚
Nursing Science.2025; 14(10): 1920. CrossRef - Global trends, risk factors, and therapeutic associations of fungal pulmonary infections in lung cancer: A systematic review and meta-analysis
Milad Sheervalilou1, Mostafa Ghanei1, Masoud Arabfard1
Jornal Brasileiro de Pneumologia.2025; : e20250076. CrossRef - Tuberculosis and Lung Cancer: Insights from a Narrative Review
Antonio-Andrei Cotea, Ancuta-Alina Constantin, Florin-Dumitru Mihaltan
Cancers.2025; 18(1): 83. CrossRef - Invasive aspergillosis complicated in a patient with non-small cell lung cancer harboring RET fusion during treatment with RET-TKIs: a case report and literature review
Kaidiriye Setiwalidi, Yimeng Li, Yuyan Ma, Zhanpeng Hao, Yujia Zhao, Yuxin Zhang, Xuan Liang, Tao Tian, Zhiping Ruan, Yu Yao, Xiao Fu
Frontiers in Oncology.2024;[Epub] CrossRef
- A Meta‐Analysis on the Incidence and Associated Factors of Pulmonary Fungal Infections in Lung Cancer Patients: Evidence Predominantly From Chinese Studies in the Chinese and English Literature
- 8,369 View
- 210 Download
- 12 Web of Science
- 14 Crossref
First
Prev
